Edition:
United States

GenMark Diagnostics Inc (GNMK.OQ)

GNMK.OQ on NASDAQ Stock Exchange Global Market

7.46USD
13 Aug 2018
Change (% chg)

-- (--)
Prev Close
$7.46
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
82,961
52-wk High
$10.31
52-wk Low
$3.63

Chart for

About

GenMark Diagnostics, Inc. is a molecular diagnostics company. The Company is focused on developing and commercializing multiplex molecular tests that aid in the diagnosis of complex medical conditions. It develops and commercializes multiplex molecular tests based on its eSensor electrochemical detection technology. It offers... (more)

Overall

Beta: 0.79
Market Cap(Mil.): $395.85
Shares Outstanding(Mil.): 55.75
Dividend: --
Yield (%): --

Financials

  GNMK.OQ Industry Sector
P/E (TTM): -- 44.63 32.45
EPS (TTM): -1.05 -- --
ROI: -66.56 7.96 12.93
ROE: -80.96 11.49 15.12

BRIEF-Genmark Diagnostics Reports First Quarter 2018 Results

* Q1 EARNINGS PER SHARE VIEW $-0.22 -- THOMSON REUTERS I/B/E/S

May 01 2018

BRIEF-Casdin Capital Reports 7 Pct Stake In Genmark Diagnostics

* CASDIN CAPITAL REPORTS A 7 PERCENT STAKE IN GENMARK DIAGNOSTICS AS OF MARCH 20 - SEC FILING Source text: [https://bit.ly/2IYGIH9] Further company coverage:

Mar 27 2018

BRIEF-Genmark Diagnostics Q4 Loss Per Share $0.26

* GENMARK DIAGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 RESULTS

Feb 27 2018

Earnings vs. Estimates